| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/23/1999 | US5874553 Phosphonomonoester nucleic acids, process for their preparation, and their use |
| 02/23/1999 | US5874541 Immunoglobulin or fragment is modified such that heavy chain variable region have been replaced by specific sequence or amino acids of a heavy chain immunogloblin comprising two heavy polypeptide chain consisting of antigen binding site |
| 02/23/1999 | US5874535 Human leptin receptor gene-related protein |
| 02/23/1999 | US5874473 Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitors |
| 02/23/1999 | US5874472 Aminoacid derivatives as no synthase inhibitors |
| 02/23/1999 | US5874459 Reducing nausea during chemotherapy; therapy for glaucoma, organ transplants |
| 02/23/1999 | US5874458 Psychological disorders |
| 02/23/1999 | US5874457 Imidazolylalkyl derivatives of imidazo 1,5-a!indol-3-one |
| 02/23/1999 | US5874454 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| 02/23/1999 | US5874445 (+) -α- (2,3-dimethoxyphenyl)-1-(2-(4-fluorephenyl) ethyl)-4-piepridinemethanol |
| 02/23/1999 | US5874433 Treating prophylaxis or hypotension induced by cytokine therapy or exposure to bacterial endotoxin by administering a nitric oxide synthase inhibitor |
| 02/23/1999 | US5874432 Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 02/23/1999 | US5874428 N-substituted aza-heterocyclic carboxylic acids and esters thereof |
| 02/23/1999 | US5874427 Substituted heteroaromatic 5-HT1F agonists |
| 02/23/1999 | US5874426 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 02/23/1999 | US5874420 Process for regulating vagal tone |
| 02/23/1999 | US5874286 Tumor proteins |
| 02/23/1999 | US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences |
| 02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
| 02/23/1999 | US5874243 OLRCC15 receptor |
| 02/23/1999 | US5874209 Regulation of transcription factor, NF-IL6/LAP |
| 02/23/1999 | US5874118 Adding urea, trimethylamine oxide to standard feed; salt water fish |
| 02/23/1999 | US5874086 Synthetic polypeptide analogs of parathyroid hormone (pth), parathyroid hormone related peptide (pthrp), and of the physiologically active truncated homologs and analogs of pth and pthrp; forming an amphipathic alpha-helix |
| 02/23/1999 | US5874085 A drug comprising at least one cytokine stimulants and a b cell activator selected from a cell surface protein and bacterial lipopolysaccharide |
| 02/23/1999 | US5874080 Administering a therapeutic polypeptide antiallergens to inhabit elastase release by neutrophils |
| 02/23/1999 | US5874071 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 02/23/1999 | CA2176255C Isoxazoline compounds as antiinflammatory agents |
| 02/23/1999 | CA2146007C Substituted quinuclidines |
| 02/23/1999 | CA2120538C Use of bisphosphonic acid derivatives for promoting bone repair and corresponding drugs |
| 02/19/1999 | CA2241433A1 Novel compounds |
| 02/18/1999 | WO1999008110A1 Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 02/18/1999 | WO1999007891A1 90 human secreted proteins |
| 02/18/1999 | WO1999007729A2 Peptides having potassium channel opener activity |
| 02/18/1999 | WO1999007700A1 Bicyclic compounds as ligands for 5-ht1 receptors |
| 02/18/1999 | WO1999007692A2 New epothilone derivatives, method for producing same and their pharmaceutical use |
| 02/18/1999 | WO1999007678A1 Indole derivatives as mcp-1 receptor antagonists |
| 02/18/1999 | WO1999007677A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 02/18/1999 | WO1999007669A1 Anthranilic acid analogs |
| 02/18/1999 | WO1999007410A1 Pharmaceutical composition with neurotrophic-like biological activity |
| 02/18/1999 | WO1999007409A1 Product comprising at least a double stranded rna combined with at least an antiviral agent |
| 02/18/1999 | WO1999007407A1 Heparin-binding growth factor (hbgf) polypeptides |
| 02/18/1999 | WO1999007406A1 C1q AND COLLECTIN RECEPTOR |
| 02/18/1999 | WO1999007402A1 METHOD TO PREVENT ACCELERATED ATHEROSCLEROSIS USING (sRAGE) SOLUBLE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS |
| 02/18/1999 | WO1999007358A1 Use of a retinoid type compound to modulate in vivo the decoupling activity of the protein ucp2 |
| 02/18/1999 | WO1999007352A2 Method for promoting expression of ldl receptor gene |
| 02/18/1999 | WO1999007351A2 Indole derivatives and their use as mcp-1 antagonists |
| 02/18/1999 | WO1998036764A3 Method of treating psychological and metabolic disorders using igf or igf/igfbp-3 |
| 02/18/1999 | WO1998014593A3 Human telomerase catalytic subunit |
| 02/18/1999 | DE19735410A1 New stable fumarate salt of pyrimidinol derivative dopamine D3 receptor ligand, having improved solubility and suitable for oral administration |
| 02/18/1999 | CA2301669A1 Peptides having potassium channel opener activity |
| 02/18/1999 | CA2299608A1 New epothilone derivatives, method for producing same and their pharmaceutical use |
| 02/18/1999 | CA2299554A1 Product comprising at least a double stranded rna combined with at least an antiviral agent |
| 02/18/1999 | CA2299467A1 Method to prevent accelerated atherosclerosis using (srage) soluble receptor for advanced glycation endproducts |
| 02/18/1999 | CA2299411A1 Heparin-binding growth factor (hbgf) polypeptides |
| 02/18/1999 | CA2299286A1 Bicyclic compounds as ligands for 5-ht1 receptors |
| 02/18/1999 | CA2299270A1 Use of a retinoid type compound to modulate in vivo the decoupling activity of the protein ucp2 |
| 02/18/1999 | CA2298701A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 02/18/1999 | CA2297412A1 Anthranilic acid analogs |
| 02/18/1999 | CA2297290A1 Chemical compounds |
| 02/18/1999 | CA2295535A1 Indole derivatives as mcp-1 receptor antagonists |
| 02/18/1999 | CA2245043A1 Ccr-3 receptor antagonists |
| 02/18/1999 | CA2245041A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 02/17/1999 | EP0897008A2 His5 |
| 02/17/1999 | EP0897001A1 Polypeptide having a GTPase regulator activity, nucleic acids coding therefore and their use in diagnostics and therapy |
| 02/17/1999 | EP0896822A1 4-Aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists |
| 02/17/1999 | EP0896626A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| 02/17/1999 | EP0896622A1 Chemokine alpha 2 |
| 02/17/1999 | EP0896586A1 ErbB3 ANTIBODIES |
| 02/17/1999 | EP0896580A1 Specific immunophilin ligands as antiasthmatics and immunosuppressants |
| 02/17/1999 | EP0896522A1 Methods of regulating skin appearance with vitamin b 3? compound |
| 02/17/1999 | CN1208417A Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 02/17/1999 | CN1208413A Antagonists of gonadotropin releasing hormone |
| 02/17/1999 | CN1208412A Antagonists of gonadotropin releasing hormone |
| 02/17/1999 | CN1208411A Benzofuran carboxamides and sulphonamides |
| 02/17/1999 | CN1208405A Retroviral protease inhibiting compounds |
| 02/17/1999 | CN1208349A Composition for treating pain |
| 02/17/1999 | CN1207942A Oral liquid |
| 02/17/1999 | CN1207941A Anti-senility medicine and its preparation |
| 02/17/1999 | CN1207896A Solid pharmaceutical dispersions with enhanced bioavailability |
| 02/17/1999 | CN1042133C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/16/1999 | US5872280 Respiratory system disorders |
| 02/16/1999 | US5872220 Antibodies to insulin-like growth factor binding protein IGFBP-6 |
| 02/16/1999 | US5872146 Metalloproteinases involved in connective tissue breakdown, such as collagenase, stromelysin and gelatinase and tumor necrosis factor |
| 02/16/1999 | US5872145 Formulation of 5-HT agonist and NSAID for treatment of migraine |
| 02/16/1999 | US5872135 Enzyme inhibitors |
| 02/16/1999 | US5872134 Antiarrthmia, stroke, central nervous systems, schizophrenia |
| 02/16/1999 | US5872129 Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents |
| 02/16/1999 | US5872119 2-Naphthamide derivatives and their therapeutic applications |
| 02/16/1999 | US5872094 Method for attaching cartilaginous tissue, cartilage matrix protein or link protein to a surface |
| 02/16/1999 | US5871982 Hybrid vectors and genes |
| 02/16/1999 | US5871973 Cell division regulators |
| 02/16/1999 | US5871950 Methods of treating autoimmune diseases and transplantation rejection |
| 02/16/1999 | US5871779 Treatment of arthropathies with vanadate compounds or analogues thereof |
| 02/16/1999 | US5871729 Superoxide dismutase-4 |
| 02/16/1999 | US5871724 Administering to the subject an amount of a transforming growth factor beta 3 effective to slow the growth of normal cells |
| 02/16/1999 | US5871464 Administration of gene therapy to target cells and tissues |
| 02/16/1999 | CA2021576C Agent for preventing and treating opacity of lens |
| 02/15/1999 | CA2224096A1 The g-protein coupled receptor hfia041 |
| 02/13/1999 | CA2240627A1 Novel ratc |
| 02/12/1999 | CA2239837A1 Novel murd |